Active ingredientNateglinideCat. No. P-N025-001CAS 105816-04-4Family · Pharmaceutical analytical standards
Nateglinide
An antidiabetic of the glinide family that triggers a rapid, short-lived release of insulin at mealtimes; approved in the United States in 2000 for type 2 diabetes. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?It is a derivative of the amino acid D-phenylalanine, the mirror-image form of the L-phenylalanine our body uses to build proteins.
Go to the active ingredient →Active ingredientNateglinideCat. No. P-N025-001CAS 105816-04-4
Pharmacopoeial impurityNateglinide EP Impurity ACat. No. P-N025-002CAS 7077-05-6
Pharmacopoeial impurityNateglinide EP Impurity BCat. No. P-N025-003CAS 105816-05-5
Pharmacopoeial impurityNateglinide EP Impurity CCat. No. P-N025-004CAS 105816-06-6
Pharmacopoeial impurityNateglinide EP Impurity ECat. No. P-N025-005CAS 105746-45-0
Pharmacopoeial impurityNateglinide EP Impurity FCat. No. P-N025-006CAS 944746-48-9
Pharmacopoeial impurityNateglinide EP Impurity GCat. No. P-N025-007CAS 187728-85-4
MetaboliteNateglinide acyl glucuronideCat. No. P-N025-008CAS 1357003-01-0
Isotopically labelledNateglinide-d5Cat. No. P-N025-009CAS 1227666-13-8
ImpurityNateglinide Impurity 1Cat. No. P-N025-011CAS 491828-09-2
ImpurityNateglinide Methyl EsterCat. No. P-N025-013CAS 105746-47-2No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Reference substanceNateglinide CRSEDQM code Y0001437Family NateglinideImpurityNateglinide impurity A CRSEDQM code Y0001440Family NateglinideImpurityNateglinide impurity B CRSEDQM code Y0001441Family NateglinideImpurityNateglinide impurity C CRSEDQM code Y0001442Family NateglinideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.